Pharmacokinetics of XueBiJing in Patients With Sepsis

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 18, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2019

Conditions
SepsisSeptic ShockCommunity Acquired Pneumonia
Interventions
DRUG

XueBiJing injection

100mL XueBiJing injection (dissolved with 100 mL of 0.9% normal saline),intravenous infusion for 1.25 h, q12h for 5 days

Trial Locations (1)

210009

Zhongda Hospital, Southeast University, Nanjing

Sponsors
All Listed Sponsors
collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

Southeast University, China

OTHER

NCT03475732 - Pharmacokinetics of XueBiJing in Patients With Sepsis | Biotech Hunter | Biotech Hunter